查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969239

血液製品市場：按交付形式、成分、加工自動化程度、製備方法、應用和最終用戶分類－2026-2032年全球預測

Blood Preparation Market by Offerings, Component, Processing Automation, Preparation Method, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年血液製品市場價值為480.9億美元，預計到2026年將成長至508.1億美元，複合年成長率為5.93%，到2032年將達到719.8億美元。

主要市場統計數據
基準年 2025 480.9億美元
預計年份：2026年 508.1億美元
預測年份 2032 719.8億美元
複合年成長率 (%) 5.93%

全面介紹目前血液製品生態系統如何影響營運策略，重點關注技術促進因素、相關人員的優先事項和採購考量。

隨著越來越多的機構要求更安全、更有效率、更可追溯的生物製藥流通，血液製品生態系統在技術和運作方面正迅速發展。採集和儲存設備的進步，以及用於設施管理和溫度監控的軟體層的不斷擴展，正在重新定義捐血和處理到儲存和分發的整個工作流程。從血庫和醫院輸血科到門診手術中心和研究機構，相關人員都在重新評估採購優先事項，以強調韌性、自動化和整合品管。

對技術、營運和採購的變革性轉變進行全面展望，重新定義血液製品產業的安全、自動化和供應商合作。

血液製品領域正沿著多個相互融合的方向發展，這些方向正在改變供應鏈和臨床實踐。首先，自動化不再局限於提高單一儀器的效率，而是發展為協調的工作流程，整合自動化的成分提取、離心和溫度感測儲存系統，從而減少人工操作和操作差異。其次，諸如白血球去除、輻照和病原體去活化等安全技術正被更早地應用於處理流程中，以降低下游風險並支援更廣泛的應用情境。第三，軟體驅動的流程管治日趨成熟，溫度監控系統和血液設施管理系統提供了審核和合規性支持，而這些功能傳統上依賴人工記錄。

對累積關稅措施如何重塑整個血液製品價值鏈的採購趨勢、供應商策略和業務連續性進行清晰分析。

近期推出的關稅措施顯著增加了整個血液製品價值鏈採購和供應的韌性難度。進口組件、資本設備和某些耗材的累積關稅提高了依賴跨境供應商的機構的總擁有成本，促使許多機構重新評估其供應商集中度和前置作業時間。因此，採購團隊正優先考慮雙重採購策略，並與本地製造商密切合作，以降低貿易政策波動帶來的風險。

將採購和創新重點與產品供應、加工方法、臨床應用、自動化程度、組件和最終用戶需求進行匹配的關鍵細分洞察。

市場區隔驅動著產品開發藍圖和採購選擇，因為最終用戶需要清楚了解產品如何滿足其臨床和營運需求。根據產品類型，市場分為「一次性耗材」、「設備」和「軟體」。一次性耗材包括血漿分離試劑盒、血袋系統、白血球去除過濾器、輸血套裝、輸液管和針頭等，這些決定了血站和醫院每次操作的成本和利潤率。設備包括採血裝置、輻照裝置、病原體移除系統、處理裝置和儲存裝置。採血裝置進一步分為血漿分離裝置和血液混合器，而處理裝置包括自動成分分離器和離心機。儲存裝置包括血庫冷藏庫、低溫冷凍庫、血漿冷凍庫、血小板培養箱和振盪器。軟體涵蓋血液設施解決方案和溫度監控平台，這些平台可實現庫存管理和監管追溯。

這份綜合情報報告分析了細微的區域差異，解釋了美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響採用率、供應彈性和監管合規性。

區域趨勢對供應鏈、法規要求以及新型血液製品技術的應用進度有顯著影響。美洲地區擁有大規模的現有血液服務基礎設施、先進的醫院系統，並且日益重視自動化和安全技術。在這種環境下，報銷機制、與現有供應商的關係以及溫控產品長途配送的物流實際情況都會影響採購決策。

可用於公司層面的競爭訊息，了解供應商策略、服務模式和夥伴關係方式如何塑造整個血液製品生態系統的競爭優勢。

血液製品產業的競爭動態更取決於其在生態系統中的定位，而非單一產品的優越性。主要企業透過整合一次性產品、資本設備和軟體能力的綜合產品組合來脫穎而出，提供端到端的價值提案，既滿足採購對可預測生命週期成本的需求，又能最大限度地減少與供應商的接觸。主要供應商採取的策略性措施包括：與臨床網路建立夥伴關係以檢驗新的處理技術；投資建置區域服務中心以縮短維護前置作業時間；以及提供培訓和認證專案以降低採用先進設備的門檻。

為血液製品產業的供應商、醫療保健系統和採購經理提供切實可行的優先建議，以增強韌性、安全性和技術整合。

產業領導者應優先採取一系列策略行動，直接提升供應的韌性、安全性和完整性。首先，他們應採用模組化籌資策略，平衡血液採集和儲存設施的資本投資與耗材和維護的長期契約，以穩定總體擁有成本，並降低關稅波動帶來的價格衝擊。其次，他們應加快血液設施管理和溫度監控軟體的整合，建立透明且審核的工作流程，以減少人為錯誤並支援合規性。

一個穩健的多方法研究框架，結合了對關鍵相關人員的訪談、對二手技術和監管資訊的整合，以及使用三角測量法進行主題檢驗，以支持策略見解。

本執行摘要的分析結合了多種研究方法，旨在得出可操作的、基於證據的見解。對二手資訊的整合利用了同行評審文獻、監管指南、技術標準和製造商規範，從而建立了技術、流程和合規要求的全面整體情況。一手研究則透過對血庫經理、醫院輸血科經理、採購負責人、臨床病理學家和醫療設備技術人員的結構化訪談進行，以確定實際應用中的限制和推動因素。

血液製品相關人員的一項關鍵要求是，要果斷地整合策略重點和營運協調，從而將安全性、韌性和完整性結合起來。

研究結果一致表明，醫療服務提供者和供應商應從基於交易的關係轉向整合價值的夥伴關係，將彈性採購、自動化和數據驅動的品質系統相結合。服務提供者應將流程自動化、病原體減少和軟體管治的投資視為策略基礎，而不僅僅是資本計劃，以實現臨床一致性和供應彈性。能夠提供模組化、服務豐富且互通性解決方案的供應商，最能滿足從門診手術中心到大型醫院網路等不同終端用戶的細微需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液製品市場：依供應方式分類

  • 一次性用品和消耗品
    • 血漿分離試劑盒
    • 血袋系統
    • 白血球去除過濾器
    • 傳輸組
    • 管子和針頭
  • 裝置
    • 採血裝置
      • 血液分離裝置
      • 血液採集混合器
    • 照射裝置
    • 病原體減少系統
    • 處理單元
      • 自動組件提取裝置
      • 離心機
    • 保藏設備
      • 血庫用冷藏庫
      • 超低溫冷凍庫
      • 等離子冷凍庫
      • 血小板培養箱及攪拌裝置
  • 軟體
    • 血液設施
    • 溫度控制

第9章 血液製品市場：依成分分類

  • 電漿
  • 血小板
  • 紅血球
  • 全血

第10章：血液製品市場加工自動化

  • 全自動
  • 手動的
  • 半自動

第11章 依製備方法分類的血液製品市場

  • 血液分離術
  • 提取工作流程
  • 冷凍/低溫保存
  • 輻射照射
  • 白血球去除
  • 病原體去活化
  • 洗滌和容量調節
  • 全血處理

第12章 血液製品市場：依應用領域分類

  • 血漿衍生療法
    • 自體免疫疾病與神經系統疾病
    • 肝病與重症監護
    • 原發性免疫力缺乏
  • 研究與生物製造
  • 輸血支持
    • 貧血管理
    • 循環系統/移植
    • 血液疾病
    • 婦產科
    • 腫瘤治療

第13章 血液製品市場：依最終用戶分類

  • 門診手術中心
  • 血庫
  • 診所
  • 醫院

第14章 血液製品市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 血液製品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 血液製品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國血液製品市場

第18章：中國血液製品市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AdvaCare Pharma
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Cardinal Health
  • CSL Limited
  • Daiichi Sankyo
  • Delcon SRL
  • Exelint International, Co.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Greiner Bio-One International GmbH
  • Grifols, SA
  • GVS SpA
  • Immucor, Inc.
  • Kedrion Holding SpA
  • Labotronics Scientific LTD.
  • Labtron Equipment Ltd
  • LFB SA
  • Macopharma SAS
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mitra Industries Private Limited
  • Nipro Corporation
  • Octapharma AG
  • Ortho Clinical Diagnostics Inc.
  • Pfizer Inc.
  • QIAGEN NV
  • Sanquin
  • SARSTEDT AG & Co. KG
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Terumo Corporation
Product Code: MRR-535C62918769

The Blood Preparation Market was valued at USD 48.09 billion in 2025 and is projected to grow to USD 50.81 billion in 2026, with a CAGR of 5.93%, reaching USD 71.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 48.09 billion
Estimated Year [2026] USD 50.81 billion
Forecast Year [2032] USD 71.98 billion
CAGR (%) 5.93%

A comprehensive orientation to the current blood preparation ecosystem highlighting technological enablers, stakeholder priorities, and procurement considerations shaping operational strategy

The blood preparation ecosystem is undergoing a period of rapid technological and operational refinement as institutions seek safer, more efficient, and more traceable flows of biological products. Advances in collection and storage hardware, combined with a growing software layer for establishment management and temperature monitoring, are redefining workflows across donation, processing, storage, and distribution. Stakeholders from blood banks and hospital transfusion services to ambulatory surgical centers and research organizations are recalibrating procurement priorities to emphasize resiliency, automation, and integrated quality controls.

Against this backdrop, procurement decision-makers must balance capital investments in collection devices, pathogen reduction systems, and storage infrastructure with recurring consumable needs such as apheresis kits, tubing, and filters. At the same time, clinical teams are emphasizing component integrity for plasma-derived therapies, transfusion support in oncology and cardiology, and specialized needs for immune and hepatic care. The introductory framing here establishes the operational tensions that follow through the analysis: securing supply continuity, minimizing contamination risk, and enabling seamless traceability through both hardware and software interventions.

An integrated view of transformative technological, operational, and procurement shifts that are redefining safety, automation, and supplier engagement across blood preparation

The landscape of blood preparation is shifting along several convergent vectors that are transforming both supply chains and clinical practice. First, automation is moving beyond single-instrument gains toward orchestrated workflows that integrate automated component extraction, centrifugation, and temperature-aware storage systems, thereby reducing manual handling and variability. Second, safety technologies such as leukoreduction, irradiation, and pathogen inactivation are becoming embedded earlier in processing pathways to reduce downstream risk and support broader clinical use cases. Third, software-enabled process governance is maturing, with temperature monitoring and blood establishment systems providing auditability and compliance support that used to rely on manual recordkeeping.

These shifts are complemented by evolving end-user expectations; hospitals and clinics are increasingly demanding modular systems that can scale with changing case mixes and regulatory requirements. Research and biomanufacturing applications are driving adaptations in processing and storage capabilities to support plasma-derived therapies and novel biologic workflows. Finally, the interplay between disposables and capital equipment is changing procurement models, encouraging suppliers to present lifecycle propositions rather than standalone product sales. Together, these transformative shifts necessitate that clinical, operational, and purchasing leaders rethink supplier relationships, maintenance models, and integration strategies to capture the full value of technological advances.

A clear analysis of how cumulative tariff measures have reshaped procurement dynamics, supplier strategies, and operational resilience across the blood preparation value chain

Recent tariff actions have introduced a material layer of complexity into procurement and supply resilience across the blood preparation value chain. Cumulative tariff measures on imported components, capital equipment, and certain consumables have increased the total cost of ownership for institutions reliant on cross-border suppliers, prompting many organizations to reassess supplier concentration and lead times. As a result, procurement teams are prioritizing dual-sourcing strategies and closer collaboration with regional manufacturers to mitigate exposure to trade policy volatility.

Operationally, tariffs have affected decisions around capital replacement cycles and servicing contracts for items such as apheresis machines, pathogen reduction systems, and temperature-sensitive storage equipment. Institutions that had planned synchronized upgrades are reconsidering schedules to avoid short-term price escalations while continuing to manage compliance and safety imperatives. On the supplier side, manufacturers are responding with localized manufacturing investments, regional distribution hubs, and revised commercial models that emphasize bundled service agreements to offset tariff-driven margins. In parallel, regulatory and customs processing requirements associated with tariff regimes are demanding greater documentation and logistics lead time, which influences blood bank inventory strategies and the timing of elective procedures that depend on reliable transfusion support.

Essential segmentation insights that map offerings, processing methods, clinical applications, automation levels, components, and end-user demands to procurement and innovation priorities

Segmentation drives both product development roadmaps and procurement choices because end users require clarity on how offerings map to clinical and operational needs. Based on offerings, the market encompasses Disposables & Consumables, Equipment, and Software. Disposables & Consumables include items such as apheresis kits, blood bag systems, leukocyte reduction filters, transfer sets, and tubing and needles that determine per-procedure cost and margin for blood centers and hospitals. Equipment comprises collection devices, irradiators, pathogen reduction systems, processing equipment, and storage equipment; collection devices further break down into apheresis machines and blood collection mixers, processing equipment includes automated component extractors and centrifuges, and storage equipment captures blood bank refrigerators, cryogenic freezers, plasma freezers, and platelet incubators and agitators. Software covers blood establishment solutions and temperature monitoring platforms that enable inventory control and regulatory traceability.

Based on component, segmentation differentiates plasma, platelets, red blood cells, and whole blood, each with distinct processing, storage, and clinical utilization profiles. Based on processing automation, offerings span fully automated systems, manual workflows, and semi-automated solutions, which influence staffing models and throughput. Based on preparation method, the range includes apheresis processing, extraction workflows, freezing and cryopreservation, irradiation, leukoreduction, pathogen inactivation, washing and volume adjustment, and whole blood processing, each requiring specific consumables and equipment footprints. Based on application, the market addresses plasma-derived therapies, research and biomanufacturing, and transfusion support; plasma-derived therapies further subdivide into autoimmune and neurologic disorders, liver disease and critical care, and primary immunodeficiency, while transfusion support addresses anemia management, cardiovascular and transplant care, hematological disorders, obstetrics and gynecology, and oncology treatments. Finally, based on end user, demand channels include ambulatory surgical centers, blood banks, clinics, and hospitals, with each end user imposing different scale and compliance requirements that affect product selection and service needs.

A nuanced regional intelligence synthesis describing how Americas, Europe Middle East Africa, and Asia-Pacific dynamics influence adoption, supply resilience, and regulatory compliance

Regional dynamics exert substantial influence on supply chains, regulatory expectations, and adoption timelines for new blood preparation technologies. The Americas context features a mix of large established blood service infrastructures, advanced hospital systems, and an increasing focus on automation and safety technologies. In this environment, procurement decisions are influenced by reimbursement frameworks, established supplier relationships, and the logistical realities of long-distance distribution for temperature-sensitive products.

Europe, the Middle East & Africa presents a heterogeneous tableau where high-regulation markets drive early adoption of compliance-oriented software and pathogen reduction technologies, while emerging markets in the region prioritize scalable, cost-effective disposables and resilient storage solutions. Adoption patterns in this region are mediated by national blood service models and regional trade dynamics. The Asia-Pacific region is characterized by rapid capacity expansion in both hospital services and plasma collection infrastructure, a growing appetite for localized manufacturing to reduce import dependency, and increasing investment in automation and digital quality systems. Across all regions, the interplay between local regulatory frameworks, tariff influences, and healthcare delivery models shapes how quickly new equipment and processes are validated and scaled.

Actionable corporate-level intelligence on how supplier strategies, service models, and partnership approaches are shaping competitive advantage across the blood preparation ecosystem

Competitive dynamics in the blood preparation space are defined less by single-product dominance and more by ecosystem positioning. Leading players differentiate through comprehensive portfolios that combine disposables, capital equipment, and software capabilities, enabling end-to-end value propositions that address procurement preference for fewer vendor interfaces and predictable lifecycle costs. Strategic behaviors observed among major suppliers include forming partnerships with clinical networks to validate new processing technologies, investing in regional service footprints to shorten maintenance lead times, and offering training and accreditation programs that lower implementation friction for sophisticated equipment.

Smaller specialized suppliers are carving sustainable niches by focusing on high-margin consumables, modular add-ons for pathogen reduction, and software modules that integrate with legacy blood establishment systems. Contract manufacturing organizations and regional device assemblers have been expanding capabilities to serve localized demand, particularly where tariff pressures incentivize domestic sourcing. Across the competitive spectrum, successful companies are aligning commercial models to emphasize bundled service agreements, data-enabled support offerings, and interoperability that eases integration with existing blood center workflows.

Practical and prioritized recommendations for suppliers, health systems, and procurement leaders to strengthen resilience, safety, and technology integration in blood preparation

Industry leaders should prioritize a portfolio of strategic actions that directly address supply resilience, safety, and integration. First, adopt a modular procurement strategy that balances capital investment in collection and storage equipment with long-term agreements for disposables and maintenance to stabilize total cost of ownership and reduce exposure to tariff-driven price shocks. Second, accelerate integration of software for blood establishment and temperature monitoring to create transparent, auditable workflows that reduce manual error and support regulatory compliance.

Third, diversify supplier relationships by qualifying regional manufacturers and contract assemblers to shorten lead times and create buffer capacity for critical consumables. Fourth, invest in phased automation that aligns with staffing realities; prioritize semi-automated interventions that deliver immediate reductions in handling risk while planning for fully automated workflows where throughput and budget permit. Fifth, create clinical-laboratory partnerships to validate pathogen reduction and leukoreduction protocols in real-world settings, generating internal evidence that supports broader adoption and payer conversations. Finally, engage proactively with policymakers and customs authorities to streamline import documentation and advocate for tariff treatment that recognizes the clinical imperative of uninterrupted blood supply.

A robust, multi-method research framework combining primary stakeholder interviews, secondary technical and regulatory synthesis, and triangulated thematic validation to underpin strategic insights

The analysis underpinning this executive summary combines a multi-method research approach designed to produce actionable, evidence-based insights. Secondary source synthesis drew on peer-reviewed literature, regulatory guidance, technical standards, and manufacturer technical specifications to build a comprehensive picture of technologies, processes, and compliance requirements. Primary research was conducted through structured interviews with blood bank directors, hospital transfusion leads, procurement professionals, clinical pathologists, and device engineers to surface real-world constraints and adoption drivers.

Data triangulation integrated qualitative interview findings with product feature mappings, supply chain case studies, and regional regulatory reviews to validate themes and identify divergence across regions and end-user types. Segmentation logic was applied iteratively to ensure that offerings, components, processing automation levels, preparation methods, applications, and end users were coherently aligned to observed purchasing behavior and clinical workflows. Where appropriate, scenario analysis was used to stress-test procurement and operational responses to tariff shifts and supply disruptions without attempting to estimate market sizes or forecast quantitative outcomes.

A decisive synthesis of strategic priorities and operational adjustments that unify safety, resilience, and integration as the central imperatives for blood preparation stakeholders

The findings converge on a clear imperative: institutions and suppliers must move from transactional interactions to integrated value partnerships that combine resilient sourcing, automation, and data-enabled quality systems. Providers should view investments in processing automation, pathogen mitigation, and software governance not merely as capital projects but as strategic enablers of clinical consistency and supply resilience. Suppliers who offer modular, service-rich, and interoperable solutions will be best positioned to meet the nuanced demands of diverse end users from ambulatory surgical centers to large hospital networks.

At the same time, procurement teams must adopt a more dynamic risk posture that accounts for tariff volatility and regional manufacturing shifts. By aligning clinical validation programs with procurement cycles and engaging in active supplier qualification, organizations can shorten time-to-adoption for high-value technologies while safeguarding continuity of supply. The conclusions here are intended to guide pragmatic decisions that improve patient safety, operational reliability, and cost transparency across the blood preparation lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Preparation Market, by Offerings

  • 8.1. Disposables & Consumables
    • 8.1.1. Apheresis Kits
    • 8.1.2. Blood Bag Systems
    • 8.1.3. Leukocyte Reduction Filters
    • 8.1.4. Transfer Sets
    • 8.1.5. Tubing & Needles
  • 8.2. Equipment
    • 8.2.1. Collection Devices
      • 8.2.1.1. Apheresis Machines
      • 8.2.1.2. Blood Collection Mixers
    • 8.2.2. Irradiators
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Processing Equipment
      • 8.2.4.1. Automated Component Extractors
      • 8.2.4.2. Centrifuges
    • 8.2.5. Storage Equipment
      • 8.2.5.1. Blood Bank Refrigerators
      • 8.2.5.2. Cryogenic Freezers
      • 8.2.5.3. Plasma Freezers
      • 8.2.5.4. Platelet Incubators & Agitators
  • 8.3. Software
    • 8.3.1. Blood Establishment
    • 8.3.2. Temperature Monitoring

9. Blood Preparation Market, by Component

  • 9.1. Plasma
  • 9.2. Platelets
  • 9.3. Red Blood Cells
  • 9.4. Whole Blood

10. Blood Preparation Market, by Processing Automation

  • 10.1. Fully Automated
  • 10.2. Manual
  • 10.3. Semi-Automated

11. Blood Preparation Market, by Preparation Method

  • 11.1. Apheresis Processing
  • 11.2. Extraction Workflow
  • 11.3. Freezing & Cryopreservation
  • 11.4. Irradiation
  • 11.5. Leukoreduction
  • 11.6. Pathogen Inactivation
  • 11.7. Washing & Volume Adjustment
  • 11.8. Whole Blood Processing

12. Blood Preparation Market, by Application

  • 12.1. Plasma-Derived Therapies
    • 12.1.1. Autoimmune & Neurologic Disorders
    • 12.1.2. Liver Disease & Critical Care
    • 12.1.3. Primary Immunodeficiency
  • 12.2. Research & Biomanufacturing
  • 12.3. Transfusion Support
    • 12.3.1. Anemia Management
    • 12.3.2. Cardiovascular & Transplant
    • 12.3.3. Hematological Disorders
    • 12.3.4. Obstetrics & Gynecology
    • 12.3.5. Oncology Treatments

13. Blood Preparation Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Blood Banks
  • 13.3. Clinics
  • 13.4. Hospitals

14. Blood Preparation Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Preparation Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Preparation Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Blood Preparation Market

18. China Blood Preparation Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AdvaCare Pharma
  • 19.7. AstraZeneca PLC
  • 19.8. B. Braun Melsungen AG
  • 19.9. Baxter International Inc.
  • 19.10. Bayer AG
  • 19.11. Becton, Dickinson, and Company
  • 19.12. Cardinal Health
  • 19.13. CSL Limited
  • 19.14. Daiichi Sankyo
  • 19.15. Delcon SRL
  • 19.16. Exelint International, Co.
  • 19.17. Fresenius Kabi AG
  • 19.18. GlaxoSmithKline PLC
  • 19.19. Greiner Bio-One International GmbH
  • 19.20. Grifols, S.A.
  • 19.21. GVS S.p.A.
  • 19.22. Immucor, Inc.
  • 19.23. Kedrion Holding S.p.A.
  • 19.24. Labotronics Scientific LTD.
  • 19.25. Labtron Equipment Ltd
  • 19.26. LFB SA
  • 19.27. Macopharma S.A.S.
  • 19.28. Medline Industries, Inc.
  • 19.29. Medtronic PLC
  • 19.30. Mitra Industries Private Limited
  • 19.31. Nipro Corporation
  • 19.32. Octapharma AG
  • 19.33. Ortho Clinical Diagnostics Inc.
  • 19.34. Pfizer Inc.
  • 19.35. QIAGEN N.V
  • 19.36. Sanquin
  • 19.37. SARSTEDT AG & Co. KG
  • 19.38. Shanghai Kohope Medical Devices Co., Ltd.
  • 19.39. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. GCC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GCC BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 314. GCC BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 315. GCC BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 316. GCC BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 317. GCC BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 318. GCC BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 319. GCC BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. GCC BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 321. GCC BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 322. GCC BLOOD PREPARATION MARKET SIZE, BY PREPARA